SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Prevest DenPro soars on opening R&D and Testing Center adjoining to Jammu factory

03 Nov 2022 Evaluate

Prevest Denpro is currently trading at Rs. 398.40, up by 12.95 points or 3.36% from its previous closing of Rs. 385.45 on the BSE.

The scrip opened at Rs. 399.85 and has touched a high and low of Rs. 399.85 and Rs. 398.35 respectively. So far 10000 shares were traded on the counter.

The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 494.50 on 09-Sep-2022 and a 52 week low of Rs. 212.50 on 29-Nov-2021.

Last one week high and low of the scrip stood at Rs. 399.85 and Rs. 375.00 respectively. The current market cap of the company is Rs. 462.66 crore.

The promoters holding in the company stood at 73.60%, while Institutions and Non-Institutions held 1.85% and 24.55% respectively.

Prevest DenPro has opened its new, one of its kind, R&D and Testing Center adjoining to its Jammu factory. This new facility is a testimony of its belief that in research & development is the backbone of business growth and will focus on the innovations in the dental field. The new facility will employ 30 highly qualified and experienced scientists, engineers, and dental professionals to carry out the research on new products development.

Prevest DenPro is the 1st Indian manufacturer to set up a research centre in the private sector. The new facility has been completed in a record time of one year with an investment of Rs 1200 lakh ($1.45 millions). The facility is spread across 16000 square feet. This facility has been equipped with required infrastructure to design & develop dental materials, conduct product reliability performance testing and verification, as well as validation of products and processes.

Prevest Denpro manufactures and markets a range of dental materials for diagnosing, treating, and preventing dental conditions and improving the aesthetics of the human smile

Prevest Denpro Share Price

440.40 6.05 (1.39%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 540.90
Poly Medicure 1480.80
Laxmi Denta 198.45
Nureca Ltd. 260.25
Hemant Surgical Inds 300.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×